+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Eye Cancer Market Research and Forecast 2018-2023

  • ID: 4621244
  • Report
  • August 2018
  • Region: Global
  • Orion Market Research Private Limited
until Dec 31st 2021


  • Abbott Laboratories Inc.
  • Allergan Plc
  • Astrazeneca Plc
  • Blink Medical Ltd.
  • F Hoffmann-La Roche Ltd.
  • Immunomedics, Inc.
The eye cancer market is expected to grow significantly during the forecast period (2018-2023). Eye cancer can be described as types of tumors that can occur in various parts of the eye. There are various types of eye cancers such as intraocular cancer, squamous cell cancer, Rhabdomyosarcoma, and Basal cell skin cancer. Some factors that are driving the growth of this sector consist of increasing prevalence of eye cancer across the globe. Government initiatives in the field of Research and Development have reinforced this sector by bringing more and more innovations and improvement in the eye care treatment. With the technological advancement various surgeries and innovative treatments have been introduced for the cure of this disease. Some of the major treatments are eye implant, artificial eyes, enucleation, and tumour resection.

Rising healthcare expenditure and widen consciousness among people across the globe are creating opportunities for future growth of this sector. However, some of the hurdles consist of high cost of medicines, unavailability of skilled professionals especially in rural areas, and side effect of the treatment. There are cases when even treatments are always not possible. In addition, longer time taken by the ocular cancer drugs to get approved by the authorized body also hampers the growth of the market.

Global eye cancer market can be segmented on the basis of types treatments and end users. According to the types, the market is bifurcated as intraocular cancer and extraocular cancer. Based on the treatment, the market is further subdivided as chemotherapy, surgery and radiation therapy, biologic therapy, hormone therapy and targeted therapy. On the basis of end user, the market is diversified as hospitals and clinics and ambulatory care centres.

Considering the geographical regions North America is expected to dominate the global eye cancer market with its capabilities of advanced technologies which leads to introduction of various innovative treatments, and high healthcare spending. Europe holds the adequate market share due to the presence of opportunities for the development of the market. Asia Pacific region being the fastest developing market of the eye cancer. Asia Pacific market is majorly ruled by the widen population with increasing awareness among them and rising medical facilities.

The major companies contributing to the global eye cancer market includes Novartis International AG, GlaxoSmithKline plc, Bayer AG, Amgen Incorporation, Bristol-Myers Squibb Company, Pfizer Incorporation, Merck & Company Incorporation, OncoMed Pharmaceuticals, Sanofi, AbbVie incorporation, and Eli Lilly and Company. The companies are coming with more and more innovations in the products and their services to enhance the market growth.

Research Methodology:

The market study of eye cancer market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases such as Cancer Research UK, National Cancer Institute, American Cancer Society and others.
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalogue
  • Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers and initial norms. The report will be delivering insights into the market for better business decisions.

Market Segmentation:

Global Eye cancer market is segmented on the basis of regional outlook and following segments:
1. Global Eye cancer Market Research and Analysis, By Types
2. Global Eye cancer Market Research and Analysis, By Treatment
3. Global Eye cancer Market Research and Analysis, By End Users
4. Global Eye cancer Market Research and Analysis, By Region

The Report Covers
  • Comprehensive research methodology of global eye cancer
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global eye cancer market.
  • Insights about market determinants which are stimulating the global eye cancer market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown


  • Abbott Laboratories Inc.
  • Allergan Plc
  • Astrazeneca Plc
  • Blink Medical Ltd.
  • F Hoffmann-La Roche Ltd.
  • Immunomedics, Inc.
1. Report Summary
1.1. Research Methods And Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview And Insights
2.1. Definition
2.2. Analyst Insights &Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest Of The World

3. Market Determinant
3.1. Motivators
3.1.1. High Incidence Of Eye Cancer
3.1.2. Government Support And Initiatives For The Treatment For Eye Cancer
3.1.3. Rising Geriatric Population Base
3.1.4. Evolution Of Different Technologies And Development Of Various Surgeries
3.2. Restraints
3.2.1. Side Effects Of The Treatment
3.2.2. Long Approval Time For The Drugs
3.2.3. High Cost Of Medicines.
3.3. Opportunities
3.3.1. Increasing Funding And Investment On Research And Development Activities By Companies
3.3.2. Robust Pipeline For Eye Cancer Drugs

4. Market Segmentation
4.1. By Type
4.1.1. Intraocular Cancer
4.1.2. Extraocular Cancer
4.2. By Treatment
4.2.1. Chemotherapy
4.2.2. Surgery And Radiation Therapy
4.2.3. Biologic Therapy
4.2.4. Hormone Therapy
4.2.5. Targeted Therapy
4.3. By End User
4.3.1. Hospitals And Clinics
4.3.2. Ambulatory Care Centres

5. Competitive Landscape
5.1. Key Market Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.1.3. Rest Of North America
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest Of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest Of The World

7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Abbvie, Inc.
7.3. Allergan Plc
7.4. Amgen, Inc.
7.5. Astrazeneca Plc
7.6. Bayer Ag
7.7. Blink Medical Ltd.
7.8. Bristol-Myers Squibb Company
7.9. Eli Lilly And Company
7.10. F Hoffmann-La Roche Ltd.
7.11. Glaxosmithkline Plc.
7.12. Immunomedics, Inc.
7.13. Iridex Corporation
7.14. Janssen Pharmaceuticals, Inc.
7.15. Merck & Co., Inc.
7.16. Novartis International Ag
7.17. Oncomed Pharmaceuticals, Inc.
7.18. Pfizer, Inc.
7.19. Sanofi S.A.
7.20. Spectrum Pharmaceuticals, Inc.
7.21. Takeda Pharmaceutical Company Ltd
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Abbvie, Inc.
  • Allergan Plc
  • Amgen, Inc.
  • Astrazeneca Plc
  • Bayer Ag
  • Blink Medical Ltd.
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • F Hoffmann-La Roche Ltd.
  • Glaxosmithkline Plc.
  • Immunomedics, Inc.
  • Iridex Corporation
  • Janssen Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Novartis International Ag
  • Oncomed Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Sanofi S.A.
  • Spectrum Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Ltd
Note: Product cover images may vary from those shown